Loading…
Pharmaceuticals and Biotechnology · NSE · period ending 2026-03-31
Loading chart…
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Interest-bearing debt / market cap | 262.63% | < 30% | Fail |
| Interest-bearing investments / market cap | 0% | < 30% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up freeCompliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.
Positive 3–6 month returns, 50-day above 200-day and price only slightly off the high indicate an emerging uptrend, despite flat 1-month performance. Volatility remains moderate, consistent with a relatively stable rising phase.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.